MHRA Class 4 Medicines Defect Information: Tostran (Testosterone 2% gel) (Kyowa Kirin Limited)
Class 4 Medicines Defect Information:Tostran (Testosterone 2% gel) (Kyowa Kirin Limited) Drug alert number: EL (23)A/33 Date issued: 31 August 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Tostran (Testosterone 2% gel), Kyowa Kirin Limited Company name: Galderma (U.K.) Limited Product name: LTostran (Testosterone [...]
The post MHRA Class 4 Medicines Defect Information: Tostran (Testosterone 2% gel) (Kyowa Kirin Limited) appeared first on Community Pharmacy England.
Recent Comments